Conf long 700 x 400

About the HSRAANZ

Founded in 2001, the Health Services Research Association of Australia & New Zealand (HSRAANZ) supports and promotes the conduct and dissemination of applied research to improve the delivery and organisation of health services in Australia and New Zealand. With a wide range of individual and corporate members from universities, research centres, government departments, independent government agencies, and consumer groups the Association bridges the gap between research and policy, as well as reflecting consumer issues. We also have two special interest groups, focussing on Emerging Researchers and Indigenous Health Services Research, both of which have a prominent role at our main conference. [read more]


First Name:
Last Name:

Member Focus

Professor Colette Browning

This month we spoke with Professor Colette Browning, Director of the RDNS Institute, our latest corporate member.

Full Profile

    • 20 OCT 16

    Cancer deaths to cost Ireland €73 billion over the next 20 years

    Researchers at the National Cancer Registry Ireland found that deaths from cancer will result in lost productivity valued at €73 billion; €13 billion in lost paid work and €60 billion in lost unpaid activities. When people die from cancer, society loses their contribution to the economy through paid work and unpaid activities such as housework, caring for relatives and volunteering. This work provides a complementary perspective on the burden of cancer in Ireland, and can be used to inform policy makers and health services about priorities for cancer care and research in the future.

    Read more →
    • 18 OCT 16

    HSRAANZ Annual General Meeting and Symposium – Health Services Research – where to from here? A review of the state and potential of HSR in Australia and New Zealand

    Registrations are now open for the Association’s Annual General Meeting and Symposium – Health Services Research – where to from here? on 1 December 2016 at the National Press Club, Canberra. At the event we will launch the preliminary findings of a commissioned report on the state and potential of HSR in Australia and New Zealand. This will be accompanied by short presentations by leading health services researchers describing the impact of their HSR on the Australian and New Zealand healthcare system and population health. Following the report launch and presentations, we will be holding break-out sessions to discuss the potential role and approaches to HSR in Australia and New Zealand in different sectors of the healthcare system (e.g. public hospitals, primary care, aged care, public health).

    Read more →
    • 18 OCT 16

    HSRAANZ Members – tell us about your research

    We want to encourage and help HSRAANZ members to publicise their research. You can do this simply, by completing our template. All we require is a 500 word summary for the HSRAANZ Blog, a 100 word summary for the HSRAANZ email newsletter and a 140 character summary for @hsraanz so that we can tweet about the paper and share a link to the blog. You can also post a photo of yourself or your team. For an example of how this can be done take a look at the post below “When newer isn’t better: We’re paying too much for patented pharmaceuticals” which looks at the latest research from our President, Jon Karnon

    Read more →
    • 18 OCT 16

    When newer isn’t better: We’re paying too much for patented pharmaceuticals.

    New pharmaceuticals are often listed on the Pharmaceutical Benefits Schedule at the same price as an equivalent pharmaceutical. Analysis of denosumab for the treatment of osteoporosis shows that the government has been paying almost $250,000 to gain the equivalent of one additional quality adjusted life year (QALY) since its comparator, alendronate went off patent. The Australian government should review listed pharmaceuticals as their comparator comes off patent to reflect the lower price of the comparator as well as any new clinical and economic data.

    Read more →
  • Featured Job of the Week

    PhD Scholarship in health economics -AusHSI

    A PhD scholarship is available for an exceptional student to complete a PhD as part of a National Health and Medical Research Council Centre of Research Excellence for Advanced Cardio-respiratory Therapies Improving OrgaN Support (CRE ACTIONS). The scholarship is available to undertake a PhD, which will focus on assessing the cost-effectiveness of Ventricular Assist Devices (VADS) and Extra-Corporeal Membrane Oxygenation (ECMO).

    More information and other jobs

  • Journal Article of the Month

    journalsGeneral Tew, Michelle, Dalziel, Kim M., Petrie, Dennis J., and Clarke, Philip M. (2016). Growth of linked hospital data use in Australia: a systematic review. Aust. Health Review , .

    This study conducted by researchers at the Centre for Health Policy at the University of Melbourne showed that the large majority (83%) of the published literature which uses linked hospital data for health research were contributed by two states, Western Australia and New South Wales while other states significantly lag behind.


Corporate Members